57316 and 33338, human ubiquitin carboxyl terminal...

Details 57316 and 33338, human ubiquitin carboxyl terminal... 57316 and 33338, human ubiquitin carboxyl terminal...

2005-06-28

2005-06-28

Patterson, Jr., Charles L. (Department: 1652)

Chemistry: molecular biology and microbiology

Enzyme , proenzyme; compositions thereof; process for...

Hydrolase

C435S325000, C435S006120, C536S023200

Reexamination Certificate

active

06911335

ABSTRACT:
The invention provides isolated nucleic acids molecules, designated 57316 or 33338 nucleic acid molecules, which encode ubiquitin carboxyl terminal hydrolase proteins. The invention also provides antisense nucleic acid molecules, recombinant expression vectors containing 57316 or 33338 nucleic acid molecules, host cells into which the expression vectors have been introduced, and non-human transgenic animals in which a 57316 or 33338 gene has been introduced or disrupted. The invention still further provides isolated 57316 or 33338 proteins, fusion proteins, antigenic peptides and anti-57316 or 33338 antibodies. Diagnostic and therapeutic methods utilizing compositions of the invention are also provided.

REFERENCES:
patent: 1 074 617 (2001-02-01), None
patent: WO 00/55177 (2000-09-01), None
patent: WO 01/23409 (2001-04-01), None
patent: WO 01/83775 (2001-11-01), None
patent: WO 02/00860 (2002-01-01), None

Affiliated with

Also associated with

Rating

57316 and 33338, human ubiquitin carboxyl terminal... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with 57316 and 33338, human ubiquitin carboxyl terminal..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and 57316 and 33338, human ubiquitin carboxyl terminal... will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-3521354